Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53

Overview of attention for article published in Frontiers in oncology, February 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 6,518 followers.

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53: Elena Tirrò, Michele Massimino, Chiara Romano, Maria Stella Pennisi, Stefania Stella, Silvia Rita Vitale, Annamaria Fidilio, Livia Manzella,… https://

18 Feb 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.